These observations, paired with the identification of LRRK2 polymorphisms associated with increased lifetime risk for developing sporadic PD 6, suggested that LRRK2 may provide a deep understanding of the molecular mechanisms of PD. Here, LRRK2 is linked to Parkinson disease.